Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial

Cascinu S

•

Labianca R

•

Barone C

altro

SOBRERO, Alberto

2007

journal article

Periodico

JOURNAL OF THE NATIONAL CANCER INSTITUTE

Archivio

http://hdl.handle.net/11390/861324

Diritti

metadata only access

Visualizzazioni

3

Data di acquisizione
Apr 19, 2024